{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:41:19Z","timestamp":1792694479000,"version":"4.5.0"},"reference-count":29,"publisher":"MyJove Corporation","issue":"82","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/50181","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T18:59:43Z","timestamp":1386010783000},"source":"Crossref","is-referenced-by-count":2,"title":["An Orthotopic Bladder Cancer Model for Gene Delivery Studies"],"prefix":"10.3791","author":[{"given":"Laura","family":"Kasman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Voelkel-Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2013,12,1]]},"reference":[{"issue":"1","key":"ref1","first-page":"10","type":"journal-article","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer. J. Clin. 62 (1), 10-29 (2012).","journal-title":"CA Cancer. J. Clin"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1940-6207.CAPR-09-0169","type":"journal-article","article-title":"Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer","volume":"2","author":"Seager","year":"2009","unstructured":"Seager, C.M., Puzio-Kuter, A.M. et al. Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer. Cancer Prev. Res. 2 (12), 1008-1014 (2009).","journal-title":"Cancer Prev. Res"},{"issue":"11","key":"ref3","first-page":"5507","type":"journal-article","article-title":"Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer","volume":"46","author":"Chodak","year":"1986","unstructured":"Chodak, G.W., Shing, Y., Borge, M., Judge, S.M. & Klagsbrun, M. Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer. Cancer Res. 46 (11), 5507-5510 (1986).","journal-title":"Cancer Res"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0022-5347(05)67617-3","type":"journal-article","article-title":"Retrovirus type C in the mouse bladder carcinoma cell line MBT-2","volume":"163","author":"De Boer","year":"2000","unstructured":"De Boer, E.C., Teppema, J.S., Steerenberg, P.A. & De Jong, W.H. Retrovirus type C in the mouse bladder carcinoma cell line MBT-2. J. Urol. 163 (6), 1999-2001 (2000).","journal-title":"J. Urol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.juro.2009.03.076","type":"journal-article","article-title":"Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer","volume":"182","author":"Lodillinsky","year":"2009","unstructured":"Lodillinsky, C., Rodriguez, V. et al. Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer. J. Urol. 182 (2), 749-755 (2009).","journal-title":"J. Urol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1464-410X.2007.07193.x","type":"journal-article","article-title":"Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model","volume":"101","author":"Jurczok","year":"2008","unstructured":"Jurczok, A., Fornara, P. & Soling, A. Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model. BJU Int. 101 (1), 120-124 (2008).","journal-title":"BJU Int"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/01.ju.0000168657.51551.49","type":"journal-article","article-title":"Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer","volume":"174","author":"Brocks","year":"2005","unstructured":"Brocks, C.P., Buttner, H. & Bohle, A. Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer. J. Urol. 174 (3), 1115-1118 (2005).","journal-title":"J. Urol"},{"issue":"20","key":"ref8","first-page":"6977","type":"journal-article","article-title":"Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter. Clin","volume":"10","author":"Wu","year":"2004","unstructured":"Wu, Q., Esuvaranathan, K. & Mahendran, R. Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter. Clin. Cancer Res. 10 (20), 6977-6984 (2004).","journal-title":"Cancer Res"},{"issue":"12","key":"ref9","first-page":"4522","type":"journal-article","article-title":"Nonviral cytokine gene therapy on an orthotopic bladder cancer model","volume":"9","author":"Wu","year":"2003","unstructured":"Wu, Q., Mahendran, R. & Esuvaranathan, K. Nonviral cytokine gene therapy on an orthotopic bladder cancer model. Clin. Cancer Res. 9 (12), 4522-4528 (2003).","journal-title":"Clin. Cancer Res"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1078-1439(02)00184-9","type":"journal-article","article-title":"Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder","volume":"7","author":"Bonfil","year":"2002","unstructured":"Bonfil, R.D., Russo, D.M., Binda, M.M., Delgado, F.M. & Vincenti, M. Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder. Urol. Oncol. 7 (4), 159-166 (2002).","journal-title":"Urol. Oncol"},{"issue":"1","key":"ref11","first-page":"357","type":"journal-article","article-title":"Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in","volume":"167","author":"Bohle","year":"2002","unstructured":"Bohle, A., Jurczok, A. et al. Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo. J. Urol. 167 (1), 357-363 (2002)."},{"issue":"12","key":"ref12","first-page":"2834","type":"journal-article","article-title":"Optimizing syngeneic orthotopic murine bladder cancer (MB49)","volume":"59","author":"Gunther","year":"1999","unstructured":"Gunther, J.H., Jurczok, A. et al. Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res. 59 (12), 2834-2837 (1999).","journal-title":"Cancer Res"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0022-5347(05)69008-8","type":"journal-article","article-title":"Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49)","volume":"161","author":"Gunther","year":"1999","unstructured":"Gunther, J.H., Frambach, M. et al. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49). J. Urol. 161 (5), 1702-1706 (1999).","journal-title":"J. Urol"},{"issue":"48","key":"ref14","doi-asserted-by":"crossref","DOI":"10.3791\/2535","type":"journal-article","article-title":"An orthotopic model of murine bladder cancer","author":"Dobek","year":"2011","unstructured":"Dobek, G.L. & Godbey, W.T. An orthotopic model of murine bladder cancer. J Vis Exp (48) (2011).","journal-title":"J Vis Exp"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"865684","DOI":"10.1155\/2011\/865684","type":"journal-article","article-title":"Tumor and microenvironment modification during progression of murine orthotopic bladder cancer","volume":"2011","author":"Tham","year":"2011","unstructured":"Tham, S.M., Ng, K.H., Pook, S.H., Esuvaranathan, K. & Mahendran, R. Tumor and microenvironment modification during progression of murine orthotopic bladder cancer. Clin. Dev. Immunol. 2011: 865684 (2011).","journal-title":"Clin. Dev. Immunol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1349-7006.2009.01426.x","type":"journal-article","article-title":"Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors","volume":"101","author":"Seow","year":"2009","unstructured":"Seow, S.W., Cai, S. et al. Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci. 101 (3), 751-758 (2009).","journal-title":"Cancer Sci"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/CJI.0b013e3181587d29","type":"journal-article","article-title":"CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity","volume":"31","author":"Mangsbo","year":"2008","unstructured":"Mangsbo, S.M., Ninalga, C., Essand, M., Loskog, A. & Totterman, T.H. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity. J. Immunother. 31 (1), 34-42 (2008).","journal-title":"J. Immunother"},{"issue":"24 Pt 1","key":"ref18","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/1078-0432.CCR-05-1817","type":"journal-article","article-title":"AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model","volume":"11","author":"Loskog","year":"2005","unstructured":"Loskog, A.S., Fransson, M.E. & Totterman, T.T. AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model. Clin. Cancer Res. 11 (24 Pt 1), 8816-8821 (2005).","journal-title":"Clin. Cancer Res"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1258\/002367705774286475","type":"journal-article","article-title":"Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy","volume":"39","author":"Loskog","year":"2005","unstructured":"Loskog, A., Ninalga, C. et al. Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy. Lab Anim 39 (4): 384-393 (2005).","journal-title":"Lab Anim"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.juro.2012.01.030","type":"journal-article","article-title":"Anti-Interleukin-10R1 Monoclonal Antibody Enhances Bacillus Calmette-Guerin Induced T-Helper Type 1 Immune Responses and Antitumor Immunity in a Mouse Orthotopic Model of Bladder Cancer","volume":"187","author":"Bockholt","year":"2012","unstructured":"Bockholt, N.A., Knudson, M.J. et al. Anti-Interleukin-10R1 Monoclonal Antibody Enhances Bacillus Calmette-Guerin Induced T-Helper Type 1 Immune Responses and Antitumor Immunity in a Mouse Orthotopic Model of Bladder Cancer. J. Urol. 187 (6), 2228-2235 (2012).","journal-title":"J. Urol"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1590\/S1807-59322011001200019","type":"journal-article","article-title":"Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model","volume":"66","author":"Watanabe","year":"2011","unstructured":"Watanabe, F.T., Chade, D.C. et al. Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model. Clinics. 66 (12), 2121-2124 (2011).","journal-title":"Clinics"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/S1677-55382008000200013","type":"journal-article","article-title":"Histopathological characterization of a syngeneic orthotopic murine bladder cancer model","volume":"34","author":"Chade","year":"2008","unstructured":"Chade, D.C., Andrade, P.M. et al. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model. Int. Braz. J. Urol. 34 (2), 220-226; discussion 226-9 (2008).","journal-title":"Int. Braz. J. Urol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1097\/01.ju.0000143860.50878.b1","type":"journal-article","article-title":"Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model","volume":"172","author":"Luo","year":"2004","unstructured":"Luo, Y., Chen, X. & O'Donnell M, A. Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model. J. Urol. 172 (6 Pt 1), 2414-2420 (2004).","journal-title":"J. Urol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3109\/0284186X.2010.549838","type":"journal-article","article-title":"The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer","volume":"50","author":"Zhang","year":"2011","unstructured":"Zhang, Z., Xu, X. et al. The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer. Acta Oncol. 50 (7), 1111-1118 (2011).","journal-title":"Acta Oncol"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.urology.2005.05.041","type":"journal-article","article-title":"Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer","volume":"66","author":"Kohno","year":"2005","unstructured":"Kohno, S., Luo, C. et al. Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer. Urology. 66 (5), 1116-1121 (2005).","journal-title":"Urology"},{"issue":"15 Pt 1","key":"ref26","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1158\/1078-0432.CCR-07-0151","type":"journal-article","article-title":"Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors","volume":"13","author":"Kikuchi","year":"2007","unstructured":"Kikuchi, E., Menendez, S. et al. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors. Clin. Cancer Res. 13 (15 Pt 1), 4511-458 (2007).","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00005392-200102000-00091","type":"journal-article","article-title":"Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium","volume":"165","author":"Siemens","year":"2001","unstructured":"Siemens, D.R., Austin, J.C., See, W.A., Tartaglia, J. & Ratliff, T.L. Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium. J. Urol. 165 (2), 667-6671 (2001).","journal-title":"J. Urol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.ju.0000070925.10039.23","type":"journal-article","article-title":"Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model","volume":"170","author":"Siemens","year":"2003","unstructured":"Siemens, D.R., Crist, S., Austin, J.C., Tartaglia, J. & Ratliff, T.L. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model. J. Urol. 170 (3), 979-984 (2003).","journal-title":"J. Urol"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1464-410X.2010.09424.x","type":"journal-article","article-title":"Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis","volume":"106","author":"Black","year":"2010","unstructured":"Black, P.C., Shetty, A. et al. Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis. BJU Int. 106 (11), 1799-1804 (2010).","journal-title":"BJU Int"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jove.com\/video\/50181\/an-orthotopic-bladder-cancer-model-for-gene-delivery-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:34:59Z","timestamp":1792694099000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/50181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":29,"journal-issue":{"issue":"82","published-online":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3791\/50181","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,1]]}}}